Does OCTREOTIDE Cause Malignant neoplasm progression? 2,306 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,306 reports of Malignant neoplasm progression have been filed in association with OCTREOTIDE (Octreotide Acetate). This represents 9.7% of all adverse event reports for OCTREOTIDE.
2,306
Reports of Malignant neoplasm progression with OCTREOTIDE
9.7%
of all OCTREOTIDE reports
610
Deaths
1,109
Hospitalizations
How Dangerous Is Malignant neoplasm progression From OCTREOTIDE?
Of the 2,306 reports, 610 (26.5%) resulted in death, 1,109 (48.1%) required hospitalization, and 95 (4.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCTREOTIDE. However, 2,306 reports have been filed with the FAERS database.
What Other Side Effects Does OCTREOTIDE Cause?
Death (3,801)
Diarrhoea (3,621)
Fatigue (2,933)
Blood pressure increased (2,799)
Needle issue (2,740)
Malaise (2,737)
Pain (2,366)
Blood pressure systolic increased (2,340)
Nausea (2,294)
Injection site pain (2,123)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which OCTREOTIDE Alternatives Have Lower Malignant neoplasm progression Risk?
OCTREOTIDE vs OCTREOTIDE\OCTREOTIDE
OCTREOTIDE vs ODEVIXIBAT
OCTREOTIDE vs OFATUMUMAB
OCTREOTIDE vs OFLOXACIN
OCTREOTIDE vs OLANZAPINE